Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-014516

Chief Business Officer acquired 4,182 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2023-06-01 Grant or award +2,091 $22.97 $48,030 22,088 D
Robb Gary Charles Chief Business Officer 2023-06-01 Grant or award +2,091 24,179 D
Loading xslF345X04/doc4.xml…